TrendingNews.today

S&P 500 5,142.30 ▲ +0.87%|NASDAQ 16,284.75 ▲ +1.12%|DOW 38,972.10 ▼ -0.23%|AAPL $192.45 ▲ +1.80%|TSLA $241.80 ▼ -2.10%|AMZN $178.92 ▲ +0.54%|GOOGL $141.20 ▲ +0.32%|MSFT $415.60 ▼ -0.15%|

S&P 500 5,142.30 ▲ +0.87%|NASDAQ 16,284.75 ▲ +1.12%|DOW 38,972.10 ▼ -0.23%|AAPL $192.45 ▲ +1.80%|TSLA $241.80 ▼ -2.10%|AMZN $178.92 ▲ +0.54%|GOOGL $141.20 ▲ +0.32%|MSFT $415.60 ▼ -0.15%|

As of Apr 1

Business1 sourcesNeutral

Biogen Snaps Up Apellis For $5.6 Billion, Adding Two New Drugs To Its Portfolio

Biogen struck a deal Tuesday to buy Apellis Pharmaceuticals for $5.6 billion. The buyout adds two approved drugs to Biogen's pipeline.

Investor's Business Daily

via Investor's Business Daily

March 31, 2026 | 4:59 PM UTCUpdated 1h ago

Share Read original

Read the full article at Investor's Business Daily →

Biogen Snaps Up Apellis For $5.6 Billion, Adding Two New Drugs To Its Portfolio

Source Verification

Corroboration Score: 1

This story was independently reported by 1 sources. Click any source to read the original article.

Investor's Business Daily

Comments

0 comments

Be respectful and constructive.

Loading comments...

Kylie Jenner and Timothee Chalamet Share Steamy Solo Beach Shots During Romantic Getaway Together

'The Pitt' Season 2 Finale to Screen in Alamo Drafthouse Movie Theaters

Related Articles

Caleffi S.p.A. Reveals Rise In Full Year Profit

Unknown-4h ago-1 sources

Asian Markets Track Wall Street Higher

Unknown-4h ago-2 sources

Public Procurement Commission to roll out MSME Procurement Integration Project

Public Procurement Commission to roll out MSME Procurement Integration Project

Unknown-8h ago-1 sources